Survival trends in glioma: Experience at a tertiary care centre
| Autor: | Ajaya N Jha, Deepak Bhangale, Rishabh Kedia, Vikas Sharma, Karanjit S Narang, Ratnadip Bose |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Oncology
Adult Male medicine.medical_specialty Pediatrics Karnofsky performance score India Tertiary care 030218 nuclear medicine & medical imaging Tertiary Care Centers 03 medical and health sciences Young Adult 0302 clinical medicine Internal medicine Glioma medicine Humans In patient Young adult Tertiary level Aged medicine.diagnostic_test business.industry Brain Neoplasms Magnetic resonance imaging Middle Aged medicine.disease Magnetic Resonance Imaging Isocitrate Dehydrogenase Isocitrate dehydrogenase Neurology Female Neurology (clinical) Neoplasm Grading business 030217 neurology & neurosurgery |
| Zdroj: | Neurology India. 65(6) |
| ISSN: | 0028-3886 |
| Popis: | Even after decades of research in the field of gliomas, the overall prognosis is still quite dismal. Several factors have been proposed that affect the outcome and survival length of patients with a glioma. Here, we present a series of 471 patients, who underwent surgical resection of their glioma at a tertiary level neurosurgical centre.We noted retrospective data of patients' age, histological tumor grade, and whether or not intraoperative magnetic resonance imaging (MRI) was used, and assessed the survival length of these patients from the day of surgery.The overall survival in our series was approximately 14 months. Predictably, those with age less than 40 years and those with Karnofsky performance score (KPS) ≥80 had longer survival than those with a higher age and KPS80; those with World Health Organisation (WHO) grade IV lesions had the shortest survival length compared to all the other grades. However, while comparing survival among other tumor grades, we did not find significant difference. Further, use of intraoperative MRI did not offer any statistically significant difference in survival.In addition to the conventional prognostic factors we need more definate ways to accurately predict survival in patients harbouring a glioma. Probably, assessing molecular characteristics of the individual tumors, such as presence of isocitrate dehydrogenase (IDH) mutation versus wild-type IDH, would help us in predicting survival more accurately. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|